At the heart of this transformation are the manufacturers of directed energy-based surgical systems, who are leading the way with cutting-edge technologies that significantly enhance patient outcomes.
We maintain our $95 per share fair value estimate following DuPont's announcement that it plans to retain the water business instead of spinning it off, and will aim to close the electronics spinoff ...